MedTrace Logo

Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

NCT02973958 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-06-29

No results posted yet for this study

Summary

Circumcision is the most common surgical procedure performed by Pediatric Urologists. Ketorolac has been shown to have an efficacy similar to morphine in multi-modal analgesic regimens without the commonly associated adverse effects. This study aims to see if giving ketorolac during the operation will result in better pain control. We hypothesize that ketorolac will result in pain control similar to morphine with a lower incidence of side effects such as nausea and vomiting.

Conditions

  • Pain, Postoperative
  • Phimosis
  • Paraphimosis
  • Balanitis

Interventions

DRUG

Bupivacaine

See active comparator description

DRUG

Sevoflurane

See active comparator description

DRUG

Acetaminophen

See active comparator description

DRUG

Ibuprofen

See active comparator description

DRUG

Ketorolac

See experimental arm description

Sponsors & Collaborators

  • Alberta Children's Hospital

    lead OTHER

Principal Investigators

  • Bryce Weber, MD FRCSC · Alberta Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-06-28
Completion
2018-06-28
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02973958 on ClinicalTrials.gov